Mineralys Therapeutics to present at Bank of America Health Care Conference May 12, 2026

Mineralys Therapeutics, a biopharmaceutical company developing treatments for hypertension and related diseases, will participate in the Bank of America Securities 2026 Health Care Conference in Las Vegas on May 11-14, 2026. The company's management will hold a fireside chat on May 12, which will be webcast live. This event offers Mineralys a platform to share updates on its lead drug candidate, lorundrostat, an aldosterone synthase inhibitor targeting hypertension and comorbidities like chronic kidney disease and obstructive sleep apnea. Investors can access the webcast through Mineralys' investor relations website.